FEXOFENADINE HYDROCHLORIDE ALLERGY Drug Patent Profile
✉ Email this page to a colleague
When do Fexofenadine Hydrochloride Allergy patents expire, and what generic alternatives are available?
Fexofenadine Hydrochloride Allergy is a drug marketed by Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Granules, Hetero Labs Ltd V, Rising, Sciegen Pharms, Sun Pharm Inds, Teva, Time Cap Labs, and Unique. and is included in ten NDAs.
The generic ingredient in FEXOFENADINE HYDROCHLORIDE ALLERGY is fexofenadine hydrochloride. There is one drug master file entry for this compound. One hundred and five suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fexofenadine Hydrochloride Allergy
A generic version of FEXOFENADINE HYDROCHLORIDE ALLERGY was approved as fexofenadine hydrochloride by L PERRIGO CO on February 24th, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FEXOFENADINE HYDROCHLORIDE ALLERGY?
- What are the global sales for FEXOFENADINE HYDROCHLORIDE ALLERGY?
- What is Average Wholesale Price for FEXOFENADINE HYDROCHLORIDE ALLERGY?
Summary for FEXOFENADINE HYDROCHLORIDE ALLERGY
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 87 |
| Raw Ingredient (Bulk) Api Vendors: | 124 |
| Clinical Trials: | 87 |
| Patent Applications: | 3,307 |
| DailyMed Link: | FEXOFENADINE HYDROCHLORIDE ALLERGY at DailyMed |
Recent Clinical Trials for FEXOFENADINE HYDROCHLORIDE ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Karuna Therapeutics | PHASE1 |
| Abbisko Therapeutics Co, Ltd | PHASE1 |
| Tanta University | PHASE2 |
Pharmacology for FEXOFENADINE HYDROCHLORIDE ALLERGY
| Drug Class | Histamine-1 Receptor Antagonist |
| Mechanism of Action | Histamine H1 Receptor Antagonists |

